TTK HEALTHCARE
Back to Cashflow Statement
|
TTK HEALTHCARE Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-22 Cr | ₹-12 Cr | ₹-10 Cr | ₹-17 Cr | ₹-10 Cr |
What is the latest Cash Flow from Financing Activities ratio of TTK HEALTHCARE ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-22 Cr |
Mar2023 | ₹-12 Cr |
Mar2022 | ₹-10 Cr |
Mar2021 | ₹-17 Cr |
Mar2020 | ₹-10 Cr |
How is Cash Flow from Financing Activities of TTK HEALTHCARE Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-22 Cr | Negative | |
Mar2023 | ₹-12 Cr | Negative | |
Mar2022 | ₹-10 Cr | Negative | |
Mar2021 | ₹-17 Cr | Negative | |
Mar2020 | ₹-10 Cr | - |
Compare Cash Flow from Financing Activities of peers of TTK HEALTHCARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TTK HEALTHCARE | ₹1,861.2 Cr | 0.5% | -11.7% | -5.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹428,557.0 Cr | 2.3% | -0.8% | 32.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,994.0 Cr | 3.2% | 1.1% | 51.5% | Stock Analytics | |
CIPLA | ₹116,494.0 Cr | 0.3% | -2% | 10% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,297.0 Cr | -1.8% | 2.7% | 12.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,035.0 Cr | 2% | 1.5% | 38% | Stock Analytics |
TTK HEALTHCARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TTK HEALTHCARE | 0.5% |
-11.7% |
-5.2% |
SENSEX | -1% |
-5% |
5.6% |
You may also like the below Video Courses